News

Special Sections

Ocular Therapeutix (OCUL) Doses First Patient in Phase 1 Macular Degeneration Trial

Edward Kim | Equities.com |

OCUL testing tyrosine kinase inhibitor implant for wet age-related macular degeneration (AMD)


Stealth BioTherapeutics Raises $78 Million in IPO for Mitochondrial Diseases

Edward Kim | Equities.com |

Dysfunctional mitochondria characterize many rare genetic and common age-related diseases.


On Valentine's Day, We Examine Advances in Heart Research via Data Analytics and AI

Edward Kim | Equities.com |

Advances in genomics, artificial intelligence and software may help predict and reduce cardiovascular risk


Ortho Regenerative Technologies Begins Final Animal Studies in Rotator Cuff Repair

Edward Kim | Equities.com |

Biopolymer designed to increase healing rates of sports related injuries to tendons, meniscus, ligaments and cartilage.


​Cautiously Optimistic about Gold Mining Stocks in Colombia

Craig Dempsey | Equities.com |

Colombia offers a motherlode of opportunities for those who know where to look (Image: Shane McLendon)


Oil Volatile Again

RoboForex | Equities.com |

On Monday, February 11, Brent is trading close to 61.50 USD and falling, although bulls were dominating the instrument last Friday.


Seres Therapeutics Refocuses Microbiome Pipeline and Cuts Staff

Edward Kim | Equities.com |

Focusing resources on ulcerative colitis, C. difficile infection and a planned immuno-oncology study.


Everything You Need to Know on VMS Deposits

Visual Capitalist | Equities.com |

Deep below the ocean’s waves, VMS deposits spew out massive amounts of minerals like copper, zinc, and gold, making them a key source of the metals we use.


Gold Breaks Lower – What Next?

Chris Vermeulen | Equities.com |

Gold has recently broken below $1315 and appears to be targeting our lower projected Fibonacci level


University of Alberta Researchers Identify a New Gene that Causes Glaucoma

Edward Kim | Equities.com |

We're following several companies pursuing next generation glaucoma treatments.


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Steve Stanulis - Stanulis Films

Equities.com's Sam Mitchell interviewing CEO Steve Stanulis of Stanulis Films.